Mbb Public Markets I LLC Pardes Biosciences, Inc. Transaction History

Mbb Public Markets I LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$1.4 - $1.95 $138,810 - $193,342	-99,150 Reduced 71.56%	39,400 $71,000
Q1 2023 May 15, 2023	BUY	$1.21 - $2.22 $131,345 - $240,981	108,550 Added 361.83%	138,550 $182,000
Q4 2022 Feb 14, 2023	BUY	$0.85 - $1.69 $25,500 - $50,700	30,000 New	30,000 $50,000

5.23M

Ticker PRDS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,320,900
Description
Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome ...

Get notified when there are updates to the investment portfolio of Mbb Public Markets I LLC, based on Form 13F filings with the SEC.

Stay updated on Mbb Public Markets I LLC with notifications on news.